ICLUSIG 1POINT Trademark

Trademark Overview


On Wednesday, May 17, 2017, a trademark application was filed for ICLUSIG 1POINT with the United States Patent and Trademark Office. The USPTO has given the ICLUSIG 1POINT trademark a serial number of 87452984. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, January 7, 2020. This trademark is owned by Millennium Pharmaceuticals, Inc.. The ICLUSIG 1POINT trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Business administration of patient reimbursement programs; business administration of medication reimbursement programs and services

Financial administration of patient reimbursement program; financial administration of medication reimbursement programs and services; providing insurance and insurance reimbursement information

Providing medical and scientific research information in the field of haematological malignancies, cancer, auto-immune and inflammatory diseases and disorders

Providing medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; Providing information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer, auto-immune diseases and inflammatory diseases and disorders
iclusig 1point

General Information


Serial Number87452984
Word MarkICLUSIG 1POINT
Filing DateWednesday, May 17, 2017
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, January 7, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 3, 2018

Trademark Statements


Indication of Colors claimedThe color(s) blue, gold, grey and white is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the word "ICLUSIG" in stylized blue lettering with a blue ball above the letter "I" partially encircled by a gold arc and to the right, a thin light grey vertical line, followed by the number "1" in white, appearing in the overlapping area of two triangles, one in grey and one in shades of blue, being partially obstructed by the letter "P" in the word "POINT", in blue stylized lettering, to the right of the triangles.
Goods and ServicesBusiness administration of patient reimbursement programs; business administration of medication reimbursement programs and services
Goods and ServicesFinancial administration of patient reimbursement program; financial administration of medication reimbursement programs and services; providing insurance and insurance reimbursement information
Goods and ServicesProviding medical and scientific research information in the field of haematological malignancies, cancer, auto-immune and inflammatory diseases and disorders
Goods and ServicesProviding medical information to patients relating to the management of hematological malignancies, cancer, auto-immune and inflammatory diseases and disorders; Providing information regarding medical services and therapeutic properties of pharmaceutical products to patients relating to the management of hematological malignancies, cancer, auto-immune diseases and inflammatory diseases and disorders
Pseudo MarkICLUSIG ONE POINT

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code8 - Abandoned
Class Status DateTuesday, January 7, 2020
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code8 - Abandoned
Class Status DateTuesday, January 7, 2020
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateTuesday, January 7, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateTuesday, January 7, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMillennium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameMillennium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Tuesday, January 7, 2020ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Tuesday, January 7, 2020ABANDONMENT - AFTER PUBLICATION
Monday, January 6, 2020TEAS EXPRESS ABANDONMENT RECEIVED
Monday, September 23, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 23, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2019EXTENSION 2 GRANTED
Wednesday, June 19, 2019EXTENSION 2 FILED
Wednesday, June 19, 2019TEAS EXTENSION RECEIVED
Tuesday, January 29, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 25, 2019EXTENSION 1 GRANTED
Friday, January 25, 2019EXTENSION 1 FILED
Friday, January 25, 2019TEAS EXTENSION RECEIVED
Tuesday, August 28, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 3, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 3, 2018PUBLISHED FOR OPPOSITION
Friday, June 22, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 13, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 18, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 18, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 18, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, November 18, 2017NON-FINAL ACTION E-MAILED
Saturday, November 18, 2017NON-FINAL ACTION WRITTEN
Wednesday, November 15, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 14, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 14, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 17, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 17, 2017NON-FINAL ACTION E-MAILED
Thursday, August 17, 2017NON-FINAL ACTION WRITTEN
Wednesday, August 9, 2017ASSIGNED TO EXAMINER
Wednesday, May 24, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, May 23, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 20, 2017NEW APPLICATION ENTERED IN TRAM